The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Motusol Max 2 % w/w gel

Teva B.V.PA1986/093/002

Main Information

Trade NameMotusol Max 2 % w/w gel
Active SubstancesDiclofenac sodium
Dosage FormGel
Licence HolderTeva B.V.
Licence NumberPA1986/093/002

Group Information

ATC CodeM02AA15 diclofenac


License statusAuthorised
Licence Issued25/08/2020
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceProduct not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 2%, maximum pack size 100 g, maximum period of treatment 14 days, limited indications.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back